WD-40
WDFC Nasdaq Household Products Financials FY2016βFY2025
WD-40's revenue rose 5.0% to $620 million in fiscal 2025. Its operating margin was 16.7%, up from 16.3% a year earlier. Free cash flow was $83 million, down 5.0%. It paid out $63 million in dividends and buybacks, 75% of free cash flow. The diluted share count fell 0.1%.
What WD-40 does
No business description yet.
- Legal name
- WD-40 COMPANY
- Fiscal year ends
- August 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000105132-25-000067
0000105132
Revenue and margins
WD-40 had $620M of revenue in fiscal 2025, up 5.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 7.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $83.4M in fiscal 2025, 13.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
WD-40 returned $62.6M to shareholders in fiscal 2025, 75% of free cash flow. The diluted share count fell 0.1%.
Value WD-40 yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$28.9M and divides by 13.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 32.3x Β· peers 22.0x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably WD-40 can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $86.0M | $37.8M | $48.1M | $46.7M | $58.1M |
| Debt incl. finance leases | $116M | $146M | $121M | $94.6M | $87.0M |
| Net debt / EBITDA | 0.3x | 1.1x | 0.7x | 0.5x | 0.3x |
| Debt / equity | 0.6x | 0.8x | 0.6x | 0.4x | 0.3x |
| Interest coverage | 37.1x | 31.9x | 16.0x | 22.5x | 30.2x |
| Current ratio | 2.8x | 2.3x | 2.8x | 2.5x | 2.8x |
| Quick ratio | 2.2x | 1.3x | 1.8x | 1.7x | 2.0x |
| Total assets | $430M | $434M | $438M | $449M | $476M |
| Total liabilities | $230M | $246M | $228M | $219M | $208M |
| Shareholders' equity | $200M | $189M | $210M | $231M | $268M |
| Net debt (β = net cash) | $29.7M | $109M | $72.4M | $47.9M | $28.9M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.6M
6 insiders
Sold, 12 months
$0.1M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Patricia Q OlsemDivision President, Americas | Sold | 200 | $234.72 | $0.0M | Form 4 |
| Aug 10, 2026 | Patricia Q OlsemDivision President, Americas | Sold | 300 | $233.73 | $0.1M | Form 4 |
| Feb 5, 2026 | David PendarvisDirector | Bought | 424 | $247.15 | $0.1M | Form 4 |
| Oct 30, 2025 | David PendarvisDirector | Bought | 523 | $196.37 | $0.1M | Form 4 |
| Oct 30, 2025 | Eric EtchartDirector | Bought | 500 | $194.02 | $0.1M | Form 4 |
| Oct 28, 2025 | Phenix Q. KiamilevVP, GC & Chief Compliance Ofcr | Bought | 55 | $200.46 | $0.0M | Form 4 |
| Oct 28, 2025 | Sara Kathleen HyzerVP, Finance & CFO | Bought | 200 | $200.46 | $0.0M | Form 4 |
| Oct 28, 2025 | Steven A BrassPresident and CEO, Director | Bought | 362 | $200.46 | $0.1M | Form 4 |
| Oct 27, 2025 | Daniel T CarterDirector | Bought | 1,000 | $199.37 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 8 / 9 | 8 / 9 |
| Accruals ratio | β7.4% | β5.1% | 0.7% |
| Altman Z'' | 8.29 | 8.40 | 9.05 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| WD-40 WDFC | $2.9B | 5.0% | 16.7% | 13.5% | 32.3% | 32.3x | 8 | |
| Inter Parfums IPAR | $3.7B | 2.5% | 18.2% | 12.8% | β | 22.0x | 4 | Compare β |
| Edgewell Personal Care EPC | $1.3B | β1.3% | 4.3% | 1.9% | 3.6% | β | 5 | Compare β |
| Spectrum Brands SPB | $1.8B | β5.2% | 4.5% | 5.9% | 5.3% | 25.2x | 6 | Compare β |
| Energizer ENR | $1.6B | 2.3% | β | 2.1% | 11.1% | 6.8x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $381M | $381M | $409M | $423M | $409M | $488M | $519M | $537M | $591M | $620M |
| Gross profit | $214M | $214M | $225M | $232M | $223M | $264M | $255M | $274M | $315M | $341M |
| Research and development | $7.7M | $8.4M | $7.0M | $6.5M | $6.0M | $5.6M | $5.1M | $6.2M | $8.0M | $8.7M |
| Operating income | $71.3M | $75.9M | $78.6M | $82.4M | $77.2M | $88.8M | $87.3M | $89.7M | $96.4M | $104M |
| Interest expense | $1.7M | $2.6M | $4.2M | $2.5M | $2.4M | $2.4M | $2.7M | $5.6M | $4.3M | $3.4M |
| Pretax income | $72.8M | $74.6M | $75.2M | $80.8M | $75.5M | $86.5M | $84.1M | $85.2M | $91.5M | $102M |
| Income tax | $20.2M | $21.7M | $10.0M | $24.9M | $14.8M | $16.3M | $16.8M | $19.2M | $21.9M | $10.6M |
| Net income | $52.6M | $52.9M | $65.2M | $55.9M | $60.7M | $70.2M | $67.3M | $66.0M | $69.6M | $91.0M |
| Diluted EPS | $3.64 | $3.72 | $4.64 | $4.02 | $4.40 | $5.09 | $4.90 | $4.83 | $5.11 | $6.69 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $65.3M | $55.6M | $64.8M | $62.9M | $72.7M | $84.7M | $2.6M | $98.4M | $92.0M | $87.9M |
| Capital expenditure | $4.4M | $20.1M | $12.4M | $13.3M | $19.3M | $15.1M | $8.3M | $6.9M | $4.2M | $4.5M |
| Free cash flow | $61.0M | $35.4M | $52.5M | $49.6M | $53.4M | $69.7M | β$5.7M | $91.5M | $87.8M | $83.4M |
| Depreciation and amortization | $6.5M | $6.8M | $7.8M | $7.6M | $7.7M | $7.0M | $8.3M | $8.2M | $9.5M | $8.2M |
| Stock-based compensation | $3.7M | $4.1M | $4.2M | $4.4M | $5.4M | $9.6M | $6.7M | $6.4M | $6.5M | $7.3M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $6.2M | $0.0M |
| Share buybacks | $32.1M | $31.1M | $22.6M | $29.6M | $16.8M | $0.0M | $29.2M | $10.4M | $8.1M | $12.3M |
| Dividends paid | $23.7M | $26.8M | $29.6M | $32.9M | $36.0M | $38.2M | $42.0M | $44.6M | $47.2M | $50.3M |
| Dividends and buybacks | $55.8M | $57.9M | $52.2M | $62.5M | $52.9M | $38.2M | $71.1M | $55.0M | $55.3M | $62.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $109M | $117M | $49.1M | $27.2M | $56.5M | $86.0M | $37.8M | $48.1M | $46.7M | $58.1M |
| Total debt | β | $134M | $62.8M | $60.2M | $114M | $116M | $146M | $121M | $94.6M | $87.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $210M | $225M | $168M | $148M | $185M | $241M | $250M | $249M | $255M | $285M |
| Current liabilities | $58.7M | $75.4M | $85.9M | $74.6M | $60.1M | $85.9M | $111M | $88.8M | $104M | $102M |
| Inventory | $31.8M | $35.3M | $36.5M | $40.7M | $41.3M | $55.8M | $104M | $86.5M | $79.1M | $79.9M |
| Property and equipment, net | $11.5M | $29.4M | $36.4M | $45.1M | $60.8M | $70.1M | $66.0M | $66.8M | $63.0M | $60.4M |
| Total assets | $340M | $370M | $317M | $303M | $363M | $430M | $434M | $438M | $449M | $476M |
| Total liabilities | $199M | $230M | $162M | $157M | $202M | $230M | $246M | $228M | $219M | $208M |
| Shareholders' equity | $140M | $139M | $156M | $146M | $160M | $200M | $189M | $210M | $231M | $268M |
| Margins | ||||||||||
| Gross margin | 56.3% | 56.2% | 55.1% | 54.9% | 54.6% | 54.0% | 49.1% | 51.0% | 53.4% | 55.1% |
| Operating margin | 18.7% | 20.0% | 19.2% | 19.5% | 18.9% | 18.2% | 16.8% | 16.7% | 16.3% | 16.7% |
| EBITDA margin | 20.4% | 21.7% | 21.2% | 21.3% | 20.8% | 19.6% | 18.4% | 18.2% | 17.9% | 18.1% |
| Net margin | 13.8% | 13.9% | 16.0% | 13.2% | 14.9% | 14.4% | 13.0% | 12.3% | 11.8% | 14.7% |
| FCF margin | 16.0% | 9.3% | 12.8% | 11.7% | 13.1% | 14.3% | β1.1% | 17.0% | 14.9% | 13.5% |
| Returns | ||||||||||
| Return on capital | β | β | 41.9% | 32.8% | 31.3% | 32.2% | 26.5% | 24.0% | 26.1% | 32.3% |
| Return on capital employed | 24.9% | 26.4% | 29.9% | 35.9% | 29.1% | 27.5% | 26.2% | 26.7% | 27.7% | 28.9% |
| Return on equity | 35.3% | 37.8% | 44.2% | 37.2% | 39.7% | 38.9% | 34.6% | 33.1% | 31.6% | 36.5% |
| Return on assets | 15.5% | 14.9% | 19.0% | 18.0% | 18.3% | 17.7% | 15.6% | 15.1% | 15.7% | 19.7% |
| Growth | ||||||||||
| Revenue growth | 0.7% | β0.0% | 7.4% | 3.6% | β3.5% | 19.5% | 6.3% | 3.6% | 9.9% | 5.0% |
| Net income growth | 17.5% | 0.6% | 23.2% | β14.3% | 8.6% | 15.7% | β4.1% | β2.0% | 5.5% | 30.7% |
| EPS growth | 19.7% | 2.2% | 24.7% | β13.4% | 9.5% | 15.7% | β3.7% | β1.4% | 5.8% | 30.9% |
| FCF growth | 23.7% | β41.9% | 48.1% | β5.5% | 7.6% | 30.6% | β108.2% | β | β4.0% | β5.1% |
| Share count change | β1.8% | β1.8% | β1.1% | β1.0% | β0.8% | 0.1% | β0.3% | β0.7% | β0.2% | β0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 0.2x | 0.2x | 0.4x | 0.7x | 0.3x | 1.1x | 0.7x | 0.5x | 0.3x |
| Debt / equity | β | 1.0x | 0.4x | 0.4x | 0.7x | 0.6x | 0.8x | 0.6x | 0.4x | 0.3x |
| Interest coverage | 41.9x | 29.4x | 18.6x | 32.4x | 31.7x | 37.1x | 31.9x | 16.0x | 22.5x | 30.2x |
| Current ratio | 3.6x | 3.0x | 2.0x | 2.0x | 3.1x | 2.8x | 2.3x | 2.8x | 2.5x | 2.8x |
| Quick ratio | 3.0x | 2.5x | 1.5x | 1.4x | 2.4x | 2.2x | 1.3x | 1.8x | 1.7x | 2.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 5.3% | 3.0% | 3.1% | 4.7% | 3.1% | 1.6% | 1.3% | 0.7% | 0.7% |
| Stock comp / revenue | 1.0% | 1.1% | 1.0% | 1.1% | 1.3% | 2.0% | 1.3% | 1.2% | 1.1% | 1.2% |
| Payouts / FCF | 91.6% | 163.5% | 99.5% | 126.1% | 99.1% | 54.9% | β | 60.1% | 63.0% | 75.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 5.0 | 6.0 | 7.0 | 4.0 | 3.0 | 8.0 | 8.0 | 8.0 |
| Altman Z'' | 7.8 | 7.5 | 8.0 | 8.4 | 8.1 | 7.9 | 7.7 | 8.3 | 8.4 | 9.1 |
| Accruals ratio | β3.7% | β0.7% | 0.1% | β2.2% | β3.6% | β3.7% | 15.0% | β7.4% | β5.1% | 0.7% |
Source: SEC EDGAR XBRL filings (CIK 0000105132). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.